Calhoun JH (1987) Problems of the lacrimal system in children. Pediatr Clin North Am 34(6):1457–1465. https://doi.org/10.1016/S0031-3955(16)36368-4
Article PubMed CAS Google Scholar
Sevel D (1981) Development and congenital abnormalities of the nasolacrimal apparatus. J Pediatr Ophthalmol Strabismus 18(5):13–19. https://doi.org/10.3928/0191-3913-19810901-06
Article PubMed CAS Google Scholar
Mac Ewen CJ, Young JDH (1991) Epiphora during the first year of life. Eye 5(5):596–600. https://doi.org/10.1038/eye.1991.103
Young JDH, Macewen CJ (1997) Fortnightly review: managing congenital lacrimal obstruction in general practice. BMJ 315(7103):293–296. https://doi.org/10.1136/bmj.315.7103.293
Article PubMed PubMed Central CAS Google Scholar
Takahashi Y, Kakizaki H, Chan WO, Selva D (2010) Management of congenital nasolacrimal duct obstruction: review Article. Acta Ophthalmol 88(5):506–513. https://doi.org/10.1111/j.1755-3768.2009.01592.x
Özdin S, Sarisoy G, Böke Ö (2017) A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients–a retrospective file review. Nord J Psychiatry 71(7):509–512. https://doi.org/10.1080/08039488.2017.1340517
Ulu SM, Dogan M, Ahsen A et al (2013) Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther 15(11):942–947. https://doi.org/10.1089/dia.2013.0097
Article PubMed CAS Google Scholar
Yılmaz M, Kayançiçek H (2018) A new inflammatory marker: elevated monocyte to HDL cholesterol ratio associated with smoking. J Clin Med 7(4):76. https://doi.org/10.3390/jcm7040076
Article PubMed PubMed Central CAS Google Scholar
Ganjali S, Gotto AM, Ruscica M et al (2018) Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol 233(12):9237–9246. https://doi.org/10.1002/jcp.27028
Article PubMed CAS Google Scholar
Wang RT, Zhang JR, Li Y, Liu T, Yu KJ (2015) Neutrophil-Lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes. J Diabetes Complications 29(2):245–249. https://doi.org/10.1016/j.jdiacomp.2014.11.006
Kumarasamy C, Sabarimurugan S, Madurantakam RM et al (2019) Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer - a protocol for systematic review and meta-analysis. Med (United States) 98(24):e14834. https://doi.org/10.1097/MD.0000000000014834
Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V (2019) Mediators Inflamm. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. 2019(1):9213074
Ozgonul C, Sertoglu E, Mumcuoglu T, Kucukevcilioglu M (2016) Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as novel biomarkers of primary open-angle glaucoma. J Glaucoma 25(10):e815–e820. https://doi.org/10.1097/IJG.0000000000000392
Polat O, Yavaş GF, İnan S, İnan ÜÜ (2015) Neutrophil-to-lymphocyte ratio as a marker in patients with non-arteritic anterior ischemic optic neuropathy. Balkan Med J 32(4):382–387. https://doi.org/10.5152/balkanmedj.2015.15689
Article PubMed PubMed Central CAS Google Scholar
Karaca EE, Özmen MC, Ekici F, Yüksel E, Türkoʇlu Z (2014) Neutrophil-to-lymphocyte ratio may predict progression in patients with keratoconus. Cornea 33(11):1168–1173. https://doi.org/10.1097/ICO.0000000000000260
Guven S, Kilic D (2021) Neutrophil to lymphocyte ratio (NLR) is a better tool rather than monocyte to high-density lipoprotein ratio (MHR) and platelet to lymphocyte ratio (PLR) in central retinal artery occlusions. Ocul Immunol Inflamm 29(5):997–1001. https://doi.org/10.1080/09273948.2020.1712433
Article PubMed CAS Google Scholar
Ozarslan Ozcan D, Kurtul BE, Ozcan SC, Elbeyli A (2022) Increased systemic immune-inflammation index levels in patients with dry eye disease. Ocul Immunol Inflamm 30(3):588–592. https://doi.org/10.1080/09273948.2020.1821899
Katowitz JA, Welsh MG (1987) Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction. Ophthalmology 94(6):698–705. https://doi.org/10.1016/S0161-6420(87)33392-5
Article PubMed CAS Google Scholar
Farrokhi S, Schüttauf F, Spitzer MS, Mehlan J (2021) Congenital nasolacrimal duct obstruction: A real-life study from the first symptoms to the results of surgical treatment. Ophthalmologe 118(10):1031–1037. https://doi.org/10.1007/s00347-020-01263-7
Le Garrec J, Abadie-Koebele C, Parienti J-J, Molgat Y, Degoumois A, Mouriaux F (2016) Nasolacrimal duct office probing in children under the age of 12 months: cure rate and cost evaluation. J Fr Ophtalmol 39(2):171–177. https://doi.org/10.1016/j.jfo.2015.06.009
Kapadia MK, Freitag SK, Woog JJ (2006) Evaluation and management of congenital nasolacrimal duct obstruction. Otolaryngol Clin North Am 39(5):959–977. https://doi.org/10.1016/j.otc.2006.08.004
Maheshwari R (2008) Success rate and cause of failure for late probing for congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus 45(3):168–171. https://doi.org/10.3928/01913913-20080501-17
Schnall BM (2013) Pediatric nasolacrimal duct obstruction. Curr Opin Ophthalmol 24(5). https://doi.org/10.1097/ICU.0b013e3283642e94
Kashkouli MB, Sadeghipour A, Kaghazkanani R, Bayat A, Pakdel F, Aghai GH (2010) Pathogenesis of primary acquired nasolacrimal duct obstruction. Orbit 29(1):11–15. https://doi.org/10.3109/01676830903207828
Primary treatment (2008) of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age. J AAPOS 12(5):445. https://doi.org/10.1016/j.jaapos.2008.03.005
Ffooks OO (1962) Dacryocystitis in infancy. Br J Ophthalmol 46(7):422. https://doi.org/10.1136/bjo.46.7.422
Article PubMed PubMed Central CAS Google Scholar
MacEwen CJ, Phillips MG, Young JDH (1994) Value of bacterial culturing in the course of congenital nasolacrimal duct (NLD) obstruction. J Pediatr Ophthalmol Strabismus 31(4):246–250. https://doi.org/10.3928/0191-3913-19940701-11
Article PubMed CAS Google Scholar
Sasaki H, Takano T, Murakami A (2013) Direct endoscopic probing for congenital lacrimal duct obstruction. Clin Exp Ophthalmol 41(8):729–734. https://doi.org/10.1111/ceo.12108
Fujimoto M, Ogino K, Matsuyama H, Miyazaki C (2016) Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction. Jpn J Ophthalmol 60(4):274–279. https://doi.org/10.1007/s10384-016-0445-1
Matsumura N, Goto S, Uchio E, Nakajima K, Fujita T, Kadonosono K (2017) Cytokine profiles of tear fluid from patients with pediatric lacrimal duct obstruction. Investig Ophthalmol Vis Sci 58(1):252–256. https://doi.org/10.1167/iovs.16-20717
Linberg JV, McCormick SA (1986) Primary acquired nasolacrimal duct obstruction: a clinicopathologic report and biopsy technique. Ophthalmology 93(8):1055–1063. https://doi.org/10.1016/S0161-6420(86)33620-0
Comments (0)